Clinical features and risk factors of invasive pulmonary aspergillosis in interstitial lung disease patients

Yin Liu, Xin Su, Min Cao, Hanyi Jiang, Tingting Zhao, Jian He, Rongfeng Qi, Yonglong XiaoResearch Square 2024 · DOI

Abstract

Background: The prevalence of invasive pulmonary aspergillosis (IPA) among patients with interstitial lung disease (ILD) is steadily increasing, leading to high mortality. The purpose of this study is to analyze the clinical features and risk factors of IPA in patients with ILD. Methods: 353 hospitalized ILD patients admitted in Nanjing Drum Tower Hospital from March 2023 and April 2024 were enrolled. The enrolled patients were divided into the IPA group (proven and probable IPA) and non-IPA group, and the clinical characteristics and prognosis were compared between the two groups. Results: Among 353 patients with ILD, 58 who suffered from IPA were identified. Among them, 2 (3.4%) episodes of proven IPA and 56 (96.6%) of probable IPA were diagnosed. The median age was 68.4 ± 8.6 years, and 35 patients were men. The forms of ILD included idiopathic pulmonary fibrosis (n = 21), interstitial pneumonia with autoimmune features (n = 13), rheumatoid arthritis related interstitial pneumonia (n = 11) and Sjögren′s syndrome (n = 4). The clinical features of IPA in ILD were cough (100.0%), dyspnea (93.1%) and fever (55.2%). Chest CT images showed traction bronchiectasis (84.5%), GGO (77.6%), honeycombing (69.0%), consolidation (44.8%) and pleural effusion (24.1%). The incidence of honeycombing and consolidation were higher in ILD patients with IPA compared to control group (P < 0.05). The main pathogens were A. fumigatus (50.0%) and A. flavus (29.3%). Following the diagnosis of IPA, all patients were treated with antifungal drugs. The overall survival rate after 90 days was 74.1%. Multivariate conditional Logistic regression analysis showed that lymphopenia (OR = 2.745, 95% CI 1.344–5.607) and honeycombing (OR = 2.915, 95% CI 1.429–5.949) were the risk factors of ILD with IPA (P < 0.05). Conclusion: IPA is one of the major complications of ILD and its prognosis is poor. Lymphopenia and honeycombing increased the risk of IPA in ILD patients.

Introduction

Invasive pulmonary aspergillosis (IPA) is a severe, often fatal fungal infection caused by Aspergillus molds. Historically, it was considered a threat primarily to severely immunocompromised patients, such as those undergoing bone marrow transplants. However, clinicians are observing a rising prevalence of IPA in patients with Interstitial Lung Disease (ILD), a group of disorders characterized by progressive lung scarring.

Diagnosing IPA in ILD patients is challenging because the underlying disease often mimics infection symptoms, and classic radiological signs like the "halo sign" are frequently absent. This study aims to identify specific clinical features and risk factors that predispose ILD patients to this opportunistic infection to facilitate earlier diagnosis.

Methods and Study Population

Researchers conducted a retrospective cohort study at Nanjing Drum Tower Hospital, analyzing 353 hospitalized ILD patients between March 2023 and April 2024. Patients were categorized into an IPA group (n=58) and a non-IPA group (n=295) based on EORTC/MSG diagnostic criteria. The study compared laboratory data, High-Resolution Computed Tomography (HRCT) imaging patterns, and 90-day survival rates.

Table 1: Baseline characteristics, symptoms, and ILD subtypes for the IPA and non-IPA study cohorts.

Key Results and Laboratory Findings

The study identified significant differences in laboratory markers and radiologic patterns between the two groups. Multivariate analysis pinpointed two major independent risk factors for IPA in ILD patients:

  1. Lymphopenia: Low white blood cell count (specifically low CD4+ T-cell counts) was a strong predictor (OR 2.745).
  2. Honeycombing: Advanced lung scarring patterns on CT (OR 2.915).
Table 2: Comparison of laboratory findings (inflammatory markers, cell counts) and HRCT patterns between the groups.

Laboratory markers such as the Neutrophil-to-Lymphocyte Ratio (NLR) and C-Reactive Protein (CRP) showed significant diagnostic value, with Area Under the Curve (AUC) values of 0.738 and 0.731, respectively. Furthermore, the 90-day survival rate was markedly lower in the IPA group (70.2%) compared to the non-IPA group (84.0%).

Discussion

The findings suggest a "structural niche" for infection; honeycombing creates damaged areas lacking natural defenses where Aspergillus spores can colonize. Interestingly, while ILD is often treated with steroids, lymphopenia proved to be a stronger independent predictor of IPA than the steroid dose itself. The presentation in ILD patients is often atypical, lacking classic signs like the "air crescent," and instead showing non-specific consolidation and pleural effusion.

Conclusion and Future Directions

IPA is a major complication of ILD associated with poor prognosis. Lymphopenia and honeycombing are critical clinical markers for identifying high-risk patients. While this single-center retrospective study provides a vital roadmap, future multi-center prospective trials are necessary to determine if early antifungal prophylaxis can improve survival in these high-risk populations.

Summary updated

Abstract

<title>Abstract</title> Background The prevalence of invasive pulmonary aspergillosis (IPA) among patients with interstitial lung disease (ILD) is steadily increasing, leading to high mortality. The purpose of this study is to analyze the clinical features and risk factors of IPA in patients with ILD. Methods 353 hospitalized ILD patients admitted in Nanjing Drum Tower Hospital from March 2023 and April 2024 were enrolled. The enrolled patients were divided into the IPA group (proven and probable IPA) and non-IPA group, and the clinical characteristics and prognosis were compared between the two groups. Results Among 353 patients with ILD, 58 who suffered from IPA were identified. Among them, 2 (3.4%) episodes of proven IPA and 56 (96.6%) of probable IPA were diagnosed. The median age was 68.4 ± 8.6 years, and 35 patients were men. The forms of ILD included idiopathic pulmonary fibrosis (n = 21), interstitial pneumonia with autoimmune features (n = 13), rheumatoid arthritis related interstitial pneumonia (n = 11) and Sjögren′s syndrome (n = 4). The clinical features of IPA in ILD were cough (100.0%), dyspnea (93.1%) and fever (55.2%). Chest CT images showed traction bronchiectasis (84.5%), GGO (77.6%), honeycombing (69.0%), consolidation (44.8%) and pleural effusion (24.1%). The incidence of honeycombing and consolidation were higher in ILD patients with IPA compared to control group (<italic>P</italic> &lt; 0.05). The main pathogens were A. fumigatus (50.0%) and A. flavus (29.3%). Following the diagnosis of IPA, all patients were treated with antifungal drugs. The overall survival rate after 90 days was 74.1%. Multivariate conditional Logistic regression analysis showed that lymphopenia (OR = 2.745, 95% CI 1.344–5.607) and honeycombing (OR = 2.915, 95% CI 1.429–5.949) were the risk factors of ILD with IPA (<italic>P</italic> &lt; 0.05). Conclusion IPA is one of the major complications of ILD and its prognosis is poor. Lymphopenia and honeycombing increased the risk of IPA in ILD patients.
BibTeX
@inproceedings{liu2024clinical,
  author = {Yin Liu and Xin Su and Min Cao and Hanyi Jiang and Tingting Zhao and Jian He and Rongfeng Qi and Yonglong Xiao},
  title = {{Clinical features and risk factors of invasive pulmonary aspergillosis in interstitial lung disease patients}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-5069345/v1},
}
Figure